TANFAC Industries Intrinsic Value
TANFACIND • Chemicals
Current Stock Price
₹2163.05
Primary Intrinsic Value
₹900.00
Market Cap
₹2163 Cr
-70.0%
Downside
Median Value
₹648.92
Value Range
₹433 - ₹1200
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
TANFACIND Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹900.00 | ₹720.00 - ₹1080.00 | -58.4% | EPS: ₹75.00, Sector P/E: 12x |
| Book Value Method | asset | ₹432.61 | ₹389.35 - ₹475.87 | -80.0% | Book Value/Share: ₹312.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹648.92 | ₹584.03 - ₹713.81 | -70.0% | Revenue/Share: ₹693.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹865.22 | ₹778.70 - ₹951.74 | -60.0% | EBITDA: ₹120.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹865.22 | ₹692.18 - ₹1038.26 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹648.92 | ₹584.03 - ₹713.81 | -70.0% | EPS Growth: 8.9%, Fair P/E: 7.1x |
| Growth Adjusted P/E | growth | ₹648.92 | ₹584.03 - ₹713.81 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹1200.00 | ₹1080.00 - ₹1320.00 | -44.5% | ROE: 24.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹648.92 | ₹584.03 - ₹713.81 | -70.0% | EPS: ₹75.00, BVPS: ₹312.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
TANFACIND Intrinsic Value Analysis
What is the intrinsic value of TANFACIND?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of TANFAC Industries (TANFACIND) is ₹648.92 (median value). With the current market price of ₹2163.05, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹432.61 to ₹1200.00, indicating ₹432.61 - ₹1200.00.
Is TANFACIND undervalued or overvalued?
Based on our multi-method analysis, TANFAC Industries (TANFACIND) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 35.14 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.63x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for TANFAC Industries
Additional stock information and data for TANFACIND
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹33 Cr | ₹12 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹34 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹44 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹37 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |